Search Results

There are 651 results for: content related to: Rational management of endocrine resistance in breast cancer

  1. Fulvestrant for hormone-sensitive metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Clara I Lee, Annabel Goodwin and Nicholas Wilcken

    Published Online : 3 JAN 2017, DOI: 10.1002/14651858.CD011093.pub2

  2. You have full text access to this Open Access content
    mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels

    Cancer Science

    Volume 99, Issue 10, October 2008, Pages: 1992–2003, Sandra E. Ghayad, Ivan Bieche, Julie A. Vendrell, Celine Keime, Rosette Lidereau, Charles Dumontet and Pascale A. Cohen

    Version of Record online : 14 OCT 2008, DOI: 10.1111/j.1349-7006.2008.00955.x

  3. Metastatic breast cancer: sequencing hormonal therapy and positioning of fulvestrant

    International Journal of Gynecological Cancer

    Volume 16, Issue s2, September 2006, Pages: 524–526, I. VERGOTE, F. AMANT, K. LEUNEN, T. VAN GORP, P. BERTELOOT and P. NEVEN

    Version of Record online : 26 SEP 2006, DOI: 10.1111/j.1525-1438.2006.00687.x

  4. You have free access to this content
    Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women

    Cancer

    Volume 98, Issue 2, 15 July 2003, Pages: 229–238, John F. R. Robertson, C. Kent Osborne, Anthony Howell, Stephen E. Jones, Louis Mauriac, Matthew Ellis, Ulrich R. Kleeberg, Steven E. Come, Ignace Vergote, Stan Gertler, Aman Buzdar, Alan Webster and Charles Morris

    Version of Record online : 2 JUN 2003, DOI: 10.1002/cncr.11468

  5. You have full text access to this OnlineOpen article
    Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsies

    International Journal of Cancer

    Volume 138, Issue 1, 1 January 2016, Pages: 146–159, Amit Agrawal, John F.R. Robertson, Kwok L. Cheung, Eleanor Gutteridge, Ian O. Ellis, Robert I. Nicholson and Julia M.W. Gee

    Version of Record online : 30 JUL 2015, DOI: 10.1002/ijc.29682

  6. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies

    British Journal of Dermatology

    Volume 158, Issue 1, January 2008, Pages: 109–115, J. Gassmueller, R. Hoffmann and A. Webster

    Version of Record online : 6 NOV 2007, DOI: 10.1111/j.1365-2133.2007.08276.x

  7. Overcoming resistance to fulvestrant (ICI182,780) by Downregulating the c-ABL Proto-Oncogene in breast cancer

    Molecular Carcinogenesis

    Volume 50, Issue 5, May 2011, Pages: 383–389, Huajun Zhao, Yuan-Hung Lo, Ling Yu and Shao-Chun Wang

    Version of Record online : 28 DEC 2010, DOI: 10.1002/mc.20721

  8. Effect of the oestrogen receptor antagonist fulvestrant on the cirrhotic rat lung

    Fundamental & Clinical Pharmacology

    Volume 29, Issue 3, June 2015, Pages: 269–277, Monique Oswald-Mammosser, Sherzad Rashid, Nelly Boehm, Arnaud Agin, Bernard Geny, Valérie Schini-Kerth and Anne Charloux

    Version of Record online : 6 APR 2015, DOI: 10.1111/fcp.12114

  9. You have full text access to this Open Access content
    Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer

    Cancer Science

    Volume 102, Issue 11, November 2011, Pages: 2038–2042, Hirokuni Ikeda, Naruto Taira, Tomohiro Nogami, Kazuhiko Shien, Masanori Okada, Tadahiko Shien, Hiroyoshi Doihara and Shinichiro Miyoshi

    Version of Record online : 1 SEP 2011, DOI: 10.1111/j.1349-7006.2011.02050.x

  10. Fulvestrant in Advanced Breast Cancer Following Tamoxifen and Aromatase Inhibition: A Single Center Experience

    The Breast Journal

    Volume 15, Issue 3, May/June 2009, Pages: 247–253, Jayson Wang, Sandeep Jain, Charles R. Coombes and Carlo Palmieri

    Version of Record online : 5 MAY 2009, DOI: 10.1111/j.1524-4741.2009.00713.x

  11. You have free access to this content
    Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways

    International Journal of Cancer

    Volume 126, Issue 2, 15 January 2010, Pages: 545–562, Sandra E. Ghayad, Julie A. Vendrell, Sabrina Ben Larbi, Charles Dumontet, Ivan Bieche and Pascale A. Cohen

    Version of Record online : 16 JUL 2009, DOI: 10.1002/ijc.24750

  12. Is fulvestrant (“Faslodex”) just another selective estrogen receptor modulator?

    International Journal of Gynecological Cancer

    Volume 16, Issue s2, September 2006, Pages: 521–523, A. HOWELL

    Version of Record online : 26 SEP 2006, DOI: 10.1111/j.1525-1438.2006.00686.x

  13. You have free access to this content
    Effects of the oestrogen receptor antagonist Fulvestrant on expression of genes that affect organization of the epididymal epithelium

    Andrology

    Volume 2, Issue 4, July 2014, Pages: 559–571, M. F. N. Pereira, S. A. F. Fernandes, A. R. Nascimento, E. R. Siu, R. A. Hess, C. A. Oliveira, C. S. Porto and M. F. M. Lazari

    Version of Record online : 30 APR 2014, DOI: 10.1111/j.2047-2927.2014.00219.x

  14. Oestrogen receptor antagonist and hair regrowth in dogs with hair cycle arrest (alopecia X)

    Veterinary Dermatology

    Volume 18, Issue 1, February 2007, Pages: 63–66, Linda A. Frank

    Version of Record online : 3 JAN 2007, DOI: 10.1111/j.1365-3164.2007.00559.x

  15. You have full text access to this Open Access content
    Heterogeneous estrogen receptor expression in circulating tumor cells suggests diverse mechanisms of fulvestrant resistance

    Molecular Oncology

    Volume 10, Issue 7, August 2016, Pages: 1078–1085, Costanza Paoletti, Jose M. Larios, Maria C. Muñiz, Kimberly Aung, Emily M. Cannell, Elizabeth P. Darga, Kelley M. Kidwell, Dafydd G. Thomas, Nahomi Tokudome, Martha E. Brown, Mark C. Connelly, David A. Chianese, Anne F. Schott, N. Lynn Henry, James M. Rae, Daniel F. Hayes

    Version of Record online : 29 APR 2016, DOI: 10.1016/j.molonc.2016.04.006

  16. Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226

    British Journal of Clinical Pharmacology

    Volume 81, Issue 6, June 2016, Pages: 1134–1141, Daniel L. Hertz, William E. Barlow, Kelley M. Kidwell, Kathy S. Albain, Ted A. Vandenberg, Shaker R. Dakhil, Nagendra R. Tirumali, Robert B. Livingston, Julie Gralow, Daniel F. Hayes, Gabriel N. Hortobagyi, Rita S. Mehta and James M. Rae

    Version of Record online : 8 APR 2016, DOI: 10.1111/bcp.12904

  17. You have full text access to this OnlineOpen article
    Activated estrogen receptor-mitogen-activated protein kinases cross talk confer acquired resistance to lapatinib

    Thoracic Cancer

    Volume 6, Issue 6, November 2015, Pages: 695–703, Zhe Li, Sheng-Sheng Yang, Pei-Hao Yin, Tao Chang, Lin-Xiang Shi, Lin Fang and Guo-En Fang

    Version of Record online : 13 FEB 2015, DOI: 10.1111/1759-7714.12239

  18. You have free access to this content
    Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma

    Cancer

    Volume 104, Issue 2, 15 July 2005, Pages: 236–239, Anthony Howell, John Pippen, Richard M. Elledge, Louis Mauriac, Ignace Vergote, Stephen E. Jones, Steven E. Come, C. Kent Osborne and John F.R. Robertson

    Version of Record online : 3 JUN 2005, DOI: 10.1002/cncr.21163

  19. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

    Intervention Review

    The Cochrane Library

    Lorna Gibson, David Lawrence, Claire Dawson and Judith Bliss

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD003370.pub3

  20. Estrogen Enhances Activity of Wnt Signaling During Osteogenesis by Inducing Fhl1 Expression

    Journal of Cellular Biochemistry

    Volume 116, Issue 7, July 2015, Pages: 1419–1430, Shao-Min Wu, Lan-Hsin Shih, Jing-Yu Lee, Yi-Jun Shen and Hu-Hui Lee

    Version of Record online : 12 MAY 2015, DOI: 10.1002/jcb.25102